Latest filing published 24 Nov 2023 for Awakn Life Sciences Corp. (1169082 BC Ltd.), €1,124.
Jonathan James Held discloses dealings in Awakn Life Sciences Corp. (1169082 BC Ltd.) to SEDI. Between 16 June 2021 and 21 November 2023, the trades on record add up to 19 filings.
No open-market sale appears; the market trades are 16 purchases worth €66k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2023: 3 purchases and no sales on the market.
A typical purchase (the median) is worth €3,130. Across 13 purchases, this insider has always bought alone, with no colleague buying within 30 days.
On 24 November 2023 came the latest disclosure, an open-market purchase for €1,124 in Awakn Life Sciences Corp. (1169082 BC Ltd.). Filings reach the SEDI feed a median of 1 day after the trade. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations